Found: 78
Select item for more details and to access through your institution.
Shifting the Cancer Screening Paradigm: Developing a Multi-Biomarker Class Approach to Multi-Cancer Early Detection Testing.
- Published in:
- Life (2075-1729), 2024, v. 14, n. 8, p. 925, doi. 10.3390/life14080925
- By:
- Publication type:
- Article
Functional impact of androgen‐targeted therapy on patients with castration‐resistant prostate cancer.
- Published in:
- BJUI Compass, 2022, v. 3, n. 6, p. 424, doi. 10.1002/bco2.179
- By:
- Publication type:
- Article
Transcriptional profiling of matched patient biopsies clarifies molecular determinants of enzalutamide-induced lineage plasticity.
- Published in:
- Nature Communications, 2022, v. 13, n. 1, p. 1, doi. 10.1038/s41467-022-32701-6
- By:
- Publication type:
- Article
The Promise of Multicancer Early Detection. Comment on Pons-Belda et al. Can Circulating Tumor DNA Support a Successful Screening Test for Early Cancer Detection? The Grail Paradigm. Diagnostics 2021, 11 , 2171.
- Published in:
- 2022
- By:
- Publication type:
- Letter
Multicancer early detection.
- Published in:
- 2022
- By:
- Publication type:
- Letter
Delivering exercise medicine to cancer survivors: has COVID-19 shifted the landscape for how and who can be reached with supervised group exercise?
- Published in:
- Supportive Care in Cancer, 2022, v. 30, n. 3, p. 1903, doi. 10.1007/s00520-021-06669-w
- By:
- Publication type:
- Article
Quality of Life of Prostate Cancer Survivors Participating in a Remotely Delivered Web-Based Behavioral Intervention Pilot Randomized Trial.
- Published in:
- Integrative Cancer Therapies, 2022, v. 21, p. 1, doi. 10.1177/15347354211063500
- By:
- Publication type:
- Article
A pilot feasibility study of Exercising Together© during radiation therapy for prostate cancer: a dyadic approach for patients and spouses.
- Published in:
- Pilot & Feasibility Studies, 2021, v. 7, n. 1, p. 1, doi. 10.1186/s40814-021-00952-7
- By:
- Publication type:
- Article
Examining Developments in Multicancer Early Detection: Highlights of New Clinical Data from Recent Conferences.
- Published in:
- American Journal of Managed Care, 2021, v. 27, p. S347, doi. 10.37765/ajmc.2021.88801
- By:
- Publication type:
- Article
Association Between Androgen Deprivation Therapy and Mortality Among Patients With Prostate Cancer and COVID-19.
- Published in:
- JAMA Network Open, 2021, v. 4, n. 11, p. e2134330, doi. 10.1001/jamanetworkopen.2021.34330
- By:
- Publication type:
- Article
Protocol for GET FIT Prostate: a randomized, controlled trial of group exercise training for fall prevention and functional improvements during and after treatment for prostate cancer.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Study protocol for the Exercising Together© trial: a randomized, controlled trial of partnered exercise for couples coping with cancer.
- Published in:
- 2021
- By:
- Publication type:
- journal article
The PATHFINDER Study: Assessment of the Implementation of an Investigational Multi-Cancer Early Detection Test into Clinical Practice.
- Published in:
- Cancers, 2021, v. 13, n. 14, p. 3501, doi. 10.3390/cancers13143501
- By:
- Publication type:
- Article
Comparison of Joint and Landmark Modeling for Predicting Cancer Progression in Men With Castration-Resistant Prostate Cancer: A Secondary Post Hoc Analysis of the PREVAIL Randomized Clinical Trial.
- Published in:
- JAMA Network Open, 2021, v. 4, n. 6, p. e2112426, doi. 10.1001/jamanetworkopen.2021.12426
- By:
- Publication type:
- Article
Quality of Life of Prostate Cancer Survivors Participating in a Remotely Delivered Web-Based Behavioral Intervention Pilot Randomized Trial.
- Published in:
- Integrative Cancer Therapies, 2021, v. 20, p. 1, doi. 10.1177/15347354211063500
- By:
- Publication type:
- Article
Feasibility and Acceptability of a Remotely Delivered, Web-Based Behavioral Intervention for Men With Prostate Cancer: Four-Arm Randomized Controlled Pilot Trial.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Phase II Study of Ipilimumab in Men With Metastatic Prostate Cancer With an Incomplete Response to Androgen Deprivation Therapy.
- Published in:
- Frontiers in Oncology, 2020, v. 10, p. N.PAG, doi. 10.3389/fonc.2020.01381
- By:
- Publication type:
- Article
A phase II randomized placebo-controlled double-blind study of salvage radiation therapy plus placebo versus SRT plus enzalutamide with high-risk PSA-recurrent prostate cancer after radical prostatectomy (SALV-ENZA).
- Published in:
- 2019
- By:
- Publication type:
- journal article
Recycling Discarded Drugs: Improving Access to Oral Antineoplastic Drugs.
- Published in:
- Oncologist, 2019, v. 24, n. 3, p. 291, doi. 10.1634/theoncologist.2018-0565
- By:
- Publication type:
- Article
Publisher Correction: Interplay between hypoxia and androgen controls a metabolic switch conferring resistance to androgen/AR-targeted therapy.
- Published in:
- Nature Communications, 2019, v. 10, n. 1, p. 1, doi. 10.1038/s41467-018-07872-w
- By:
- Publication type:
- Article
Implementing a comprehensive translational oncology platform: from molecular testing to actionability.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Interplay between hypoxia and androgen controls a metabolic switch conferring resistance to androgen/AR-targeted therapy.
- Published in:
- Nature Communications, 2018, v. 9, n. 1, p. 1, doi. 10.1038/s41467-018-07411-7
- By:
- Publication type:
- Article
Concordance of Circulating Tumor DNA and Matched Metastatic Tissue Biopsy in Prostate Cancer.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2018, v. 110, n. 1, p. 1, doi. 10.1093/jnci/djx118
- By:
- Publication type:
- Article
Concordance of Circulating Tumor DNA and Matched Metastatic Tissue Biopsy in Prostate Cancer.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Management of Castration-Resistant, Taxane-Resistant Prostate Cancer.
- Published in:
- Oncology (08909091), 2017, v. 31, n. 8, p. 633
- By:
- Publication type:
- Article
Falls and Frailty in Prostate Cancer Survivors: Current, Past, and Never Users of Androgen Deprivation Therapy.
- Published in:
- Journal of the American Geriatrics Society, 2017, v. 65, n. 7, p. 1414, doi. 10.1111/jgs.14795
- By:
- Publication type:
- Article
Health-related quality of life effects of enzalutamide in patients with metastatic castration-resistant prostate cancer: an in-depth post hoc analysis of EQ-5D data from the PREVAIL trial.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Cyclooxygenase-2 ( COX-2) inhibition for prostate cancer chemoprevention: double-blind randomised study of pre-prostatectomy celecoxib or placebo.
- Published in:
- BJU International, 2017, v. 119, n. 5, p. 709, doi. 10.1111/bju.13612
- By:
- Publication type:
- Article
Benefits of partnered strength training for prostate cancer survivors and spouses: results from a randomized controlled trial of the Exercising Together project.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Enzalutamide in Japanese patients with chemotherapy-naïve, metastatic castration-resistant prostate cancer: A post-hoc analysis of the placebo-controlled PREVAIL trial.
- Published in:
- International Journal of Urology, 2016, v. 23, n. 5, p. 395, doi. 10.1111/iju.13072
- By:
- Publication type:
- Article
Treatment of Nonmetastatic Castration-Resistant Prostate Cancer.
- Published in:
- Oncology (08909091), 2016, v. 30, n. 4, p. 338
- By:
- Publication type:
- Article
Building on Last Year's Advances.
- Published in:
- Oncology (08909091), 2015, v. 29, n. 7, p. 504
- By:
- Publication type:
- Article
Resistance Exercise Reduces Body Fat and Insulin During Androgen-Deprivation Therapy for Prostate Cancer.
- Published in:
- Oncology Nursing Forum, 2015, v. 42, n. 4, p. 348, doi. 10.1188/15.ONF.348-356
- By:
- Publication type:
- Article
Reducing Skeletal-Related Events in Metastatic Castration-Resistant Prostate Cancer.
- Published in:
- Oncology (08909091), 2015, v. 29, n. 6, p. 416
- By:
- Publication type:
- Article
Reducing Skeletal-Related Events in Metastatic Castration-Resistant Prostate Cancer.
- Published in:
- 2015
- By:
- Publication type:
- Journal Article
Bevicizumab and thrombosis: Some answers but questions remain.
- Published in:
- 2015
- By:
- Publication type:
- Editorial
Chemotherapy-Induced Monoamine Oxidase Expression in Prostate Carcinoma Functions as a Cytoprotective Resistance Enzyme and Associates with Clinical Outcomes.
- Published in:
- PLoS ONE, 2014, v. 9, n. 9, p. 1, doi. 10.1371/journal.pone.0104271
- By:
- Publication type:
- Article
The role of C-reactive protein in prostate cancer.
- Published in:
- Cancer (0008543X), 2013, v. 119, n. 18, p. 3262, doi. 10.1002/cncr.28211
- By:
- Publication type:
- Article
Malate dehydrogenase 2 confers docetaxel resistance via regulations of JNK signaling and oxidative metabolism.
- Published in:
- Prostate, 2013, v. 73, n. 10, p. 1028, doi. 10.1002/pros.22650
- By:
- Publication type:
- Article
Targeted Therapy in Prostate Cancer: Is There Hope Beyond the Androgen Receptor?
- Published in:
- Oncology (08909091), 2013, v. 27, n. 7, p. 628
- By:
- Publication type:
- Article
Feasibility of shutter-speed DCE-MRI for improved prostate cancer detection.
- Published in:
- Magnetic Resonance in Medicine, 2013, v. 69, n. 1, p. 171, doi. 10.1002/mrm.24211
- By:
- Publication type:
- Article
Treatment-induced damage to the tumor microenvironment promotes prostate cancer therapy resistance through WNT16B.
- Published in:
- Nature Medicine, 2012, v. 18, n. 9, p. 1359, doi. 10.1038/nm.2890
- By:
- Publication type:
- Article
Toward predictors of survival in castration-resistant prostate cancer.
- Published in:
- Cancer (0008543X), 2011, v. 117, n. 17, p. 3882, doi. 10.1002/cncr.25986
- By:
- Publication type:
- Article
Ixabepilone, mitoxantrone, and prednisone for metastatic castration-resistant prostate cancer after docetaxel-based therapy: A phase 2 study of the department of defense prostate cancer clinical trials consortium.
- Published in:
- 2011
- By:
- Publication type:
- Journal Article
Ixabepilone, mitoxantrone, and prednisone for metastatic castration-resistant prostate cancer after docetaxel-based therapy.
- Published in:
- Cancer (0008543X), 2011, v. 117, n. 11, p. 2419, doi. 10.1002/cncr.25810
- By:
- Publication type:
- Article
A HIF-Regulated VHL-PTP1B-Src Signaling Axis Identifies a Therapeutic Target in Renal Cell Carcinoma.
- Published in:
- Science Translational Medicine, 2011, v. 3, n. 85, p. 1, doi. 10.1126/scitranslmed.3002004
- By:
- Publication type:
- Article
Serum 25-OH vitamin D levels and risk of developing prostate cancer in older men.
- Published in:
- 2010
- By:
- Publication type:
- journal article
Phase 1/2 Study of Preoperative Docetaxel and Mitoxantrone for High-Risk Prostate Cancer.
- Published in:
- Cancer (0008543X), 2010, v. 116, n. 7, p. 1699, doi. 10.1002/cncr.24960
- By:
- Publication type:
- Article
CCL2 is induced by chemotherapy and protects prostate cancer cells from docetaxel-induced cytotoxicity.
- Published in:
- Prostate, 2010, v. 70, n. 4, p. 433, doi. 10.1002/pros.21077
- By:
- Publication type:
- Article
A phase II study of high-dose calcitriol combined with mitoxantrone and prednisone for androgen-independent prostate cancer.
- Published in:
- BJU International, 2008, v. 102, n. 11, p. 1601, doi. 10.1111/j.1464-410X.2008.08017.x
- By:
- Publication type:
- Article